Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs

Gabsang Lee, Eirini P. Papapetrou, Hyesoo Kim, Stuart M. Chambers, Mark J. Tomishima, Christopher A. Fasano, Yosif M. Ganat, Jayanthi Menon, Fumiko Shimizu, Agnes Viale, Viviane Tabar, Michel Sadelain, Lorenz Studer

Research output: Contribution to journalArticle

Abstract

The isolation of human induced pluripotent stem cells (iPSCs) offers a new strategy for modelling human disease. Recent studies have reported the derivation and differentiation of disease-specific human iPSCs. However, a key challenge in the field is the demonstration of disease-related phenotypes and the ability to model pathogenesis and treatment of disease in iPSCs. Familial dysautonomia (FD) is a rare but fatal peripheral neuropathy, caused by a point mutation in the IKBKAP gene involved in transcriptional elongation. The disease is characterized by the depletion of autonomic and sensory neurons. The specificity to the peripheral nervous system and the mechanism of neuron loss in FD are poorly understood owing to the lack of an appropriate model system. Here we report the derivation of patient-specific FD-iPSCs and the directed differentiation into cells of all three germ layers including peripheral neurons. Gene expression analysis in purified FD-iPSC-derived lineages demonstrates tissue-specific mis-splicing of IKBKAP in vitro. Patient-specific neural crest precursors express particularly low levels of normal IKBKAP transcript, suggesting a mechanism for disease specificity. FD pathogenesis is further characterized by transcriptome analysis and cell-based assays revealing marked defects in neurogenic differentiation and migration behaviour. Furthermore, we use FD-iPSCs for validating the potency of candidate drugs in reversing aberrant splicing and ameliorating neuronal differentiation and migration. Our study illustrates the promise of iPSC technology for gaining new insights into human disease pathogenesis and treatment.

Original languageEnglish (US)
Pages (from-to)402-406
Number of pages5
JournalNature
Volume461
Issue number7262
DOIs
StatePublished - Sep 17 2009
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • General

Cite this

Lee, G., Papapetrou, E. P., Kim, H., Chambers, S. M., Tomishima, M. J., Fasano, C. A., Ganat, Y. M., Menon, J., Shimizu, F., Viale, A., Tabar, V., Sadelain, M., & Studer, L. (2009). Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature, 461(7262), 402-406. https://doi.org/10.1038/nature08320